Aza G. Rakhmanova

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Journal: Journal of viral hepatitis

Published: January 07, 2015

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

Journal: Journal of viral hepatitis

Published: January 07, 2015

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Journal: Journal of viral hepatitis

Published: January 07, 2015

Regional differences in self-reported HIV care and management in the EuroSIDA study.

Regional differences in self-reported HIV care and management in the EuroSIDA study.

Journal: Journal of the International AIDS Society

Published: November 14, 2014

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.

Journal: Infection

Published: March 26, 2014

Chronic viral hepatitis in St.Petersburg

Chronic viral hepatitis in St.Petersburg

Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii

Published: June 29, 2013

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.

Journal: The European respiratory journal

Published: June 15, 2013

TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality.

TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality.

Journal: BioMed research international

Published: January 01, 2013

VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.

VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.

Journal: PloS one

Published: June 20, 2012

The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.

The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.

Journal: Antiviral therapy

Published: March 05, 2012

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study.

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study.

Journal: BMC infectious diseases

Published: February 27, 2012

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.

Journal: PloS one

Published: February 06, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026